Gabapentin Capsule
Product Images NDC 83301-0004

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 83301-0004). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mullan Pharmaceutical Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Gabapenin 01)

Chemical structure of Gabapentin, shown as a molecular diagram with a cyclohexane ring and attached functional groups representing amine and carboxylic acid groups.*

FDA Label Image

Figure 1 (Gabapenin 02)

A line graph depicting mean pain scores over an 8-week period comparing placebo and Gabapentin 3,600 mg/day groups. The x-axis represents weeks from baseline to week 8, while the y-axis shows mean pain scores from 0 to 10. The graph distinguishes a 4-week dose titration period followed by a 4-week fixed dose period, with Gabapentin group showing decreasing pain scores over time compared to placebo.*

FDA Label Image

Figure 2 (Gabapenin 03)

A line graph showing mean pain scores over a period of 7 weeks comparing placebo and two doses of gabapentin (1,800 mg/day and 2,400 mg/day). The timeline is divided into a 3-week dose titration period followed by a 4-week fixed dose period, with mean pain scores plotted on the y-axis and weeks on the x-axis.*

FDA Label Image

Figure 3 (Gabapenin 04)

A bar chart comparing two studies showing percentage outcomes for placebo (PBO) and Gabapentin (GBP) at different dosages. Study 1 compares PBO to GBP 3,600 mg, and Study 2 compares PBO to GBP 1,800 mg and GBP 2,400 mg, with statistical significance indicated for GBP groups.*

FDA Label Image

Figure 4 (Gabapenin 05)

A chart depicting the percentage difference versus daily dose (mg) of Gabapentin across three studies labeled a, b, and c. The chart shows data points at doses ranging approximately from 600 mg to 1800 mg, with percentage differences from about 2% to 22%. Each study is represented by different colored squares, comparing outcomes by daily dose.*

FDA Label Image

Gabapentin 100mg 100ct (83301 003 1 Gabapentin Caps 100mg 100ct Rev 08 2025)

Label for Gabapentin Capsules USP, 100 mg, manufactured by CSPC Ouyi Pharmaceutical Co., Ltd. and labeled by Mullan Pharmaceutical Inc. The label states a package quantity of 100 capsules, includes storage instructions at 25°C with permitted excursions, and a QR code area for GTIN, serial number, expiration date, and lot number. It also features barcodes and Mullan branding logos.*

FDA Label Image

Gabapentin 100mg 500ct (83301 003 2 Gabapentin Caps 100mg 500ct Rev 08 2025)

Gabapentin Capsules, USP 100 mg oral capsules label by Mullan Pharmaceutical Inc., NDC 83301-0003-2. The label states storage instructions and manufacturer details, indicating the package contains 500 capsules and is Rx only.*

FDA Label Image

Gabapentin 100mg 1000ct (83301 003 3 Gabapentin Caps 100mg 1000ct Rev 08 2025)

Label for Gabapentin Capsules, USP, 100 mg strength, manufactured for Mullan Pharmaceutical Inc. This prescription drug label includes storage instructions, medication guide information for pharmacists, and manufacturer details of CSPC Ouyi Pharmaceutical Co., Ltd. The package contains 1000 capsules and features a barcode and the Mullan and CSPC logos.*

FDA Label Image

Gabapentin 300mg 100ct (83301 004 1 Gabapentin Caps 300mg 100ct Rev 08 2025)

Gabapentin Capsules USP 300 mg oral capsules label showing the drug name, strength, and manufacturer information. The label includes storage instructions, a barcode, NDC number 83301-0004-1, dispensing directions for pharmacists, and states the package contains 100 capsules. Manufactured for Mullan Pharmaceutical Inc. and by CSPC Ouyi Pharmaceutical Co., Ltd., China.*

FDA Label Image

Gabapentin 300mg 500ct (83301 004 2 Gabapentin Caps 300mg 500ct Rev 08 2025)

Label for Gabapentin Capsules, USP 300 mg, oral dosage form by Mullan Pharmaceutical Inc. The label shows the NDC 83301-0004-2, packaging of 500 capsules, and storage instructions. Manufactured by CSPC Ouyi Pharmaceutical Co., Ltd., China. Barcode and QR code included.*

FDA Label Image

Gabapentin 300mg 1000ct (83301 004 3 Gabapentin Caps 300mg 1000ct Rev 08 2025)

Label for Gabapentin Capsules USP, 300 mg, manufactured for Mullan Pharmaceutical Inc. The label includes storage instructions, manufacturer details, and specifies this is a prescription medication. The package contains 1000 capsules. The label features barcodes, a QR code, and Mullan logos.*

FDA Label Image

Gabapentin 400mg 100ct (83301 005 1 Gabapentin Caps 400mg 100ct Rev 08 2025)

Label for Gabapentin Capsules USP 400 mg by Mullan Pharmaceutical Inc. The label includes storage instructions, manufacturer details, and pharmacist dispensing information. The package contains 100 capsules and features the NDC 83301-0005-1 barcode.*

FDA Label Image

Gabapentin 400mg 500ct (83301 005 2 Gabapentin Caps 400mg 500ct Rev 08 2025)

Label for Gabapentin Capsules USP 400 mg, oral capsules, manufactured by CSPC Ouyi Pharmaceutical Co., Ltd. for Mullan Pharmaceutical Inc. The label indicates a package size of 500 capsules and includes storage instructions to keep at 25°C with permitted excursions between 15° to 30°C. The NDC number is 83301-0005-2.*

FDA Label Image

Gabapentin 400mg 1000ct (83301 005 3 Gabapentin Caps 400mg 1000ct Rev 08 2025)

Gabapentin Capsules USP 400 mg oral capsules label by Mullan Pharmaceutical Inc., NDC 83301-0005-3. The label includes storage instructions, dispensing guidance, and indicates a package size of 1000 capsules. Manufactured by CSPC Ouyi Pharmaceutical Co., Ltd., China. Contains a barcode and QR code for medication guide access.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.